{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:03:14Z","timestamp":1791352994288,"version":"4.3.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1016\/j.cellimm.2011.08.015","type":"journal-article","created":{"date-parts":[[2011,8,25]],"date-time":"2011-08-25T00:26:19Z","timestamp":1314231979000},"page":"455-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1\/Th17 cytokines and up-regulated T regulatory cells"],"prefix":"10.1016","volume":"271","author":[{"given":"Xiao-Li","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Chun","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wen","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Li","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2011.08.015_b0005","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/jaut.1998.0259","article-title":"Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelination","volume":"12","author":"Deretzi","year":"1999","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2011.08.015_b0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","article-title":"Immunopathogenesis and treatment of the Guillain\u2013Barre syndrome \u2013 Part I","volume":"18","author":"Hartung","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cellimm.2011.08.015_b0015","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/clin.1997.4356","article-title":"Cytokine dichotomy in peripheral nervous system influences the outcome of experimental allergic neuritis: dynamics of mRNA expression for IL-1 beta, IL-6, IL-10, IL-12, TNF-alpha, TNF-beta, and cytolysin","volume":"84","author":"Zhu","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3109\/01902141003739715","article-title":"Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbits","volume":"36","author":"Duan","year":"2010","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.cellimm.2011.08.015_b0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2010.10.006","article-title":"Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia","volume":"214","author":"Puccetti","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cellimm.2011.08.015_b0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152807780077291","article-title":"T lymphocytes as targets of statins: molecular mechanisms and therapeutic perspectives","volume":"6","author":"Ghittoni","year":"2007","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1016\/j.cellimm.2011.08.015_b0035","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fj.02-1014fje","article-title":"Lovastatin inhibits brain endothelial cell rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis","volume":"17","author":"Greenwood","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.cellimm.2011.08.015_b0040","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.bbmt.2009.08.013","article-title":"Blocking LFA-1 activation with lovastatin prevents graft-versus-host disease in mouse bone marrow transplantation","volume":"15","author":"Wang","year":"2009","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.cellimm.2011.08.015_b0045","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021425","article-title":"Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin","volume":"197","author":"Aktas","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2011.08.015_b0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2011.08.015_b0055","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.4049\/jimmunol.180.10.6988","article-title":"Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes","volume":"180","author":"Zhang","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1189\/jlb.0205064","article-title":"Differential effects of statins on relevant functions of human monocyte-derived dendritic cells","volume":"79","author":"Yilmaz","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0065","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2011.08.015_b0070","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1172\/JCI200423395","article-title":"CD4+ Tregs and immune control","volume":"114","author":"Fehervari","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellimm.2011.08.015_b0075","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","article-title":"Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis","volume":"27","author":"Mor","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0080","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2007.07.031","article-title":"The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells","volume":"197","author":"Mausner-Fainberg","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.cellimm.2011.08.015_b0085","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1471-4159.1973.tb07519.x","article-title":"Myelination in rat brain: method of myelin isolation","volume":"21","author":"Norton","year":"1973","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellimm.2011.08.015_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bjo.2004.050401","article-title":"The effects of atorvastatin in experimental autoimmune uveitis","volume":"89","author":"Thomas","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1440-1711.2006.01430.x","article-title":"Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats","volume":"84","author":"Li","year":"2006","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaut.2005.06.005","article-title":"Effects of atorvastatin on the Th1\/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats","volume":"25","author":"Liu","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2011.08.015_b0105","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2011.08.015_b0110","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of T(H)17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cellimm.2011.08.015_b0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1006\/exnr.2000.7357","article-title":"Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role","volume":"163","author":"Pelidou","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0120","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2990.2009.01016.x","article-title":"FTY720 attenuates lesional interleukin-17(+) cell accumulation in rat experimental autoimmune neuritis","volume":"35","author":"Zhang","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2009.09.010","article-title":"AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis","volume":"216","author":"Zhang","year":"2009","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0130","doi-asserted-by":"crossref","first-page":"409","DOI":"10.4049\/jimmunol.161.1.409","article-title":"Enhancing effect of IL-17 on IL-1-induced IL-6 and leukemia inhibitory factor production by rheumatoid arthritis synoviocytes and its regulation by Th2 cytokines","volume":"161","author":"Chabaud","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0135","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/BOR.0b013e328304b6b5","article-title":"IL-17 and the Th17 lineage in systemic lupus erythematosus","volume":"20","author":"Garrett-Sinha","year":"2008","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","article-title":"IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis","volume":"177","author":"Komiyama","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0145","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.4049\/jimmunol.170.3.1524","article-title":"A novel anti-inflammatory role for simvastatin in inflammatory arthritis","volume":"170","author":"Leung","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0150","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.4049\/jimmunol.174.4.2327","article-title":"Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction","volume":"174","author":"Gegg","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0155","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nri1845","article-title":"Dendritic cells in a mature age","volume":"6","author":"Reis","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0160","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1084\/jem.20021215","article-title":"Immune tolerance after delivery of dying cells to dendritic cells in situ","volume":"196","author":"Liu","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2011.08.015_b0165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0170","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-4159.2006.04309.x","article-title":"Lovastatin attenuates nerve injury in an animal model of Guillain\u2013Barre syndrome","volume":"100","author":"Sarkey","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cellimm.2011.08.015_b0175","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2011.08.015_b0180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nm0804-801","article-title":"Regulatory T cells and mechanisms of immune system control","volume":"10","author":"O\u2019Garra","year":"2004","journal-title":"Nat. Med."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874911002164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874911002164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:48:58Z","timestamp":1757803738000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874911002164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"alternative-id":["S0008874911002164"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2011.08.015","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1\/Th17 cytokines and up-regulated T regulatory cells","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2011.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}